Related Experiment Video

Updated: Jun 15, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

Optimal two-stage designs allowing flexibility in number of subjects for phase II clinical trials

Nobuyuki Masaki1, Tatsuki Koyama, Isao Yoshimura

  • 1Department of Biostatistics, Bristol-Myers K.K, Tokyo, Japan. nobuyuki.masaki@bms.com

Journal of Biopharmaceutical Statistics
|February 26, 2010
PubMed

Insights

This study introduces flexible two-stage designs for Phase II clinical trials, improving upon existing methods for drug development. The new designs offer better control over statistical errors while allowing for more adaptable sample sizes.

Area of Science:

  • Clinical Trials
  • Biostatistics
  • Pharmaceutical Research

Background:

  • Phase II clinical trials evaluate drug efficacy and guide further development.
  • Commonly use one-arm designs with response rate as the primary endpoint.
  • Two-stage designs aim for early termination due to futility, but rigid sample size adherence is challenging.

Purpose of the Study:

  • To propose extended two-stage clinical trial designs with flexible sampling plans.
  • To offer improved methods for controlling Type I and Type II error probabilities.
  • To present optimal designs for various error rates and response rates.

Main Methods:

  • Extending simple two-stage designs to incorporate flexible sampling at both stages.
  • Developing designs that are preferable to existing extensions for error control.
  • Utilizing more lenient assumptions for the distribution of sample size at stage 1.

Main Results:

  • Proposed flexible designs offer advantages over similar extensions in controlling error probabilities.
  • The new designs accommodate variations in actual sample size more effectively.
  • A comprehensive list of optimal designs is provided for practical application.

Conclusions:

  • Flexible two-stage designs enhance the adaptability of Phase II clinical trials.
  • These designs provide robust statistical control while allowing for practical sample size adjustments.
  • The presented optimal designs support informed decision-making in drug development pathways.

More Related Videos

A Workflow for Lipid Nanoparticle (LNP) Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models (SVEM)13:54

A Workflow for Lipid Nanoparticle (LNP) Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models (SVEM)

Published on: August 18, 2023

A Within-Subject Experimental Design using an Object Location Task in Rats09:28

A Within-Subject Experimental Design using an Object Location Task in Rats

Published on: May 6, 2021

Related Concept Videos

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Crossover Experiments01:16

Crossover Experiments

Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...